Gerlach, S.L.; Metcalf, J.S.; Dunlop, R.A.; Banack, S.A.; Her, C.; Krishnan, V.V.; Göransson, U.; Gunasekera, S.; Slazak, B.; Cox, P.A.
Kalata B1 Enhances Temozolomide Toxicity to Glioblastoma Cells. Biomedicines 2024, 12, 2216.
https://doi.org/10.3390/biomedicines12102216
AMA Style
Gerlach SL, Metcalf JS, Dunlop RA, Banack SA, Her C, Krishnan VV, Göransson U, Gunasekera S, Slazak B, Cox PA.
Kalata B1 Enhances Temozolomide Toxicity to Glioblastoma Cells. Biomedicines. 2024; 12(10):2216.
https://doi.org/10.3390/biomedicines12102216
Chicago/Turabian Style
Gerlach, Samantha L., James S. Metcalf, Rachael A. Dunlop, Sandra Anne Banack, Cheenou Her, Viswanathan V. Krishnan, Ulf Göransson, Sunithi Gunasekera, Blazej Slazak, and Paul Alan Cox.
2024. "Kalata B1 Enhances Temozolomide Toxicity to Glioblastoma Cells" Biomedicines 12, no. 10: 2216.
https://doi.org/10.3390/biomedicines12102216
APA Style
Gerlach, S. L., Metcalf, J. S., Dunlop, R. A., Banack, S. A., Her, C., Krishnan, V. V., Göransson, U., Gunasekera, S., Slazak, B., & Cox, P. A.
(2024). Kalata B1 Enhances Temozolomide Toxicity to Glioblastoma Cells. Biomedicines, 12(10), 2216.
https://doi.org/10.3390/biomedicines12102216